Clinical Study on Toxin-Relieving and Collateral-Unblocking and Kidney-Nourishing Capsule for Diabetic Nephropathy
PU Chun-li
Abstract
PU Chun-li
Abstract
To observe the clinical efficacy of toxin-relieving and collateral-unblocking and kidney-nourishing therapy for diabetic nephropathy, 150 subjects were randomized into two groups: treatment group in which both Chinese and western medicines were given and control group in which only western medicine was given. After 12-week treatment, the symptom score, kidney function, blood lipid and blood rheology were observed. Results: The total effective rate was 86.67% in treatment group and 73.34% in control group; treatment group was superior to control group in the improvement of FBG, HbALc, CRE, BUN, urine albumin excretion rate, 24h urine total protein, urine MCP-1, TC, TG, HPL-c and LDL-C (P0.05 or P0.01). It is indicated that this therapy is effective for diabetic nephropathy.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
To observe the clinical efficacy of toxin-relieving and collateral-unblocking and kidney-nourishing therapy for diabetic nephropathy, 150 subjects were randomized into two groups: treatment group in which both Chinese and western medicines were given and control group in which only western medicine was given. After 12-week treatment, the symptom score, kidney function, blood lipid and blood rheology were observed. Results: The total effective rate was 86.67% in treatment group and 73.34% in control group; treatment group was superior to control group in the improvement of FBG, HbALc, CRE, BUN, urine albumin excretion rate, 24h urine total protein, urine MCP-1, TC, TG, HPL-c and LDL-C (P0.05 or P0.01). It is indicated that this therapy is effective for diabetic nephropathy.
Key concepts: Medicine, Diabetic nephropathy, Renal function, Urine, Capsule, Internal medicine, Kidney, Traditional Chinese medicine